Literature DB >> 31365296

The lipidated connexin mimetic peptide SRPTEKT-Hdc is a potent inhibitor of Cx43 channels with specificity for the pS368 phospho-isoform.

Maura L Cotter1, Scott Boitano1,2,3, Paul D Lampe4, Joell L Solan4, Josef Vagner3,5, Jose F Ek-Vitorin1, Janis M Burt1.   

Abstract

Connexin (Cx) mimetic peptides derived from extracellular loop II sequences (e.g., Gap27: SRPTEKTIFII; Peptide5: VDCFLSRPTEKT) have been used as reversible, Cx-specific blockers of hemichannel (HCh) and gap junction channel (GJCh) function. These blockers typically require high concentrations (~5 µM, <1 h for HCh; ~100 µM, >1 h for GJCh) to achieve inhibition. We have shown that addition of a hexadecyl (Hdc) lipid tail to the conserved SRPTEKT peptide sequence (SRPTEKT-Hdc) results in a novel, highly efficacious, and potent inhibitor of mechanically induced Ca2+-wave propagation (IC50 64.8 pM) and HCh-mediated dye uptake (IC50 45.0 pM) in Madin-Darby canine kidney cells expressing rat Cx43 (MDCK43). The lack of similar effect on dye coupling (NBD-MTMA) suggested channel conformation-specific inhibition. Here we report that SRPTEKT-Hdc inhibition of Ca2+-wave propagation, dye coupling, and dye uptake depended on the functional configuration of Cx43 as determined by phosphorylation at serine 368 (S368). Ca2+-wave propagation was enhanced in MDCK cells expressing single-site mutants of Cx43 that mimicked (MDCK43-S368D) or favored (MDCK43-S365A) phosphorylation at S368. Furthermore, SRPTEKT-Hdc potently inhibited GJCh-mediated Ca2+-wave propagation (IC50 230.4 pM), dye coupling, and HCh-mediated dye uptake in MDCK43-S368D and -S365A cells. In contrast, Ca2+-wave propagation, dye coupling, and dye uptake were largely unaffected (IC50 12.3 μM) by SRPTEKT-Hdc in MDCK43-S368A and -S365D cells, mutations that mimic or favor dephosphorylation at S368. Together, these data indicate that SRPTEKT-Hdc is a potent inhibitor of physiological Ca2+-wave signaling mediated specifically by the pS368 phosphorylated form of Cx43.

Entities:  

Keywords:  Ca2+-wave propagation; conformation-specific gap junction channel inhibitor; connexin 43; hemichannel inhibitor

Mesh:

Substances:

Year:  2019        PMID: 31365296      PMCID: PMC6850999          DOI: 10.1152/ajpcell.00160.2019

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  75 in total

1.  Mechanism of v-Src- and mitogen-activated protein kinase-induced reduction of gap junction communication.

Authors:  G Trevor Cottrell; Rui Lin; Bonnie J Warn-Cramer; Alan F Lau; Janis M Burt
Journal:  Am J Physiol Cell Physiol       Date:  2002-10-16       Impact factor: 4.249

Review 2.  Structural basis for the selective permeability of channels made of communicating junction proteins.

Authors:  Jose F Ek-Vitorin; Janis M Burt
Journal:  Biochim Biophys Acta       Date:  2012-02-10

3.  A synthetic inhibitor of the mitogen-activated protein kinase cascade.

Authors:  D T Dudley; L Pang; S J Decker; A J Bridges; A R Saltiel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 4.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

5.  Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial.

Authors:  Christina L Grek; G M Prasad; Vijay Viswanathan; David G Armstrong; Robert G Gourdie; Gautam S Ghatnekar
Journal:  Wound Repair Regen       Date:  2015-04-29       Impact factor: 3.617

6.  Selectivity of connexin 43 channels is regulated through protein kinase C-dependent phosphorylation.

Authors:  Jose F Ek-Vitorin; Timothy J King; Nathanael S Heyman; Paul D Lampe; Janis M Burt
Journal:  Circ Res       Date:  2006-05-18       Impact factor: 17.367

7.  Alterations of phosphorylation state of connexin 43 during hypoxia and reoxygenation are associated with cardiac function.

Authors:  Satoshi Matsushita; Hidetake Kurihara; Makino Watanabe; Takao Okada; Tatsuo Sakai; Atsushi Amano
Journal:  J Histochem Cytochem       Date:  2005-11-28       Impact factor: 2.479

8.  Autoregulation of connexin43 gap junction formation by internally translated isoforms.

Authors:  James W Smyth; Robin M Shaw
Journal:  Cell Rep       Date:  2013-11-07       Impact factor: 9.423

9.  Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury.

Authors:  Nan Wang; Elke De Vuyst; Raf Ponsaerts; Kerstin Boengler; Nicolás Palacios-Prado; Joris Wauman; Charles P Lai; Marijke De Bock; Elke Decrock; Mélissa Bol; Mathieu Vinken; Vera Rogiers; Jan Tavernier; W Howard Evans; Christian C Naus; Feliksas F Bukauskas; Karin R Sipido; Gerd Heusch; Rainer Schulz; Geert Bultynck; Luc Leybaert
Journal:  Basic Res Cardiol       Date:  2012-11-08       Impact factor: 17.165

10.  Phosphorylation at S365 is a gatekeeper event that changes the structure of Cx43 and prevents down-regulation by PKC.

Authors:  Joell L Solan; Lucrecia Marquez-Rosado; Paul L Sorgen; Perry J Thornton; Philip R Gafken; Paul D Lampe
Journal:  J Cell Biol       Date:  2007-12-17       Impact factor: 10.539

View more
  6 in total

1.  [Inhibition connexin 43 by mimetic peptide Gap27 mediates protective effects on 6-hydroxydopamine induced Parkinson's disease mouse model].

Authors:  H H Quan; W X Xu; Y Z Qi; Q R Li; H Zhou; J Huang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-06-18

2.  Connexin 43 hyper-phosphorylation at serine 282 triggers apoptosis in rat cardiomyocytes via activation of mitochondrial apoptotic pathway.

Authors:  Zhi-Ping Fu; Lu-Lin Wu; Jing-Yi Xue; Lan-E Zhang; Chen Li; Hong-Jie You; Da-Li Luo
Journal:  Acta Pharmacol Sin       Date:  2021-12-20       Impact factor: 7.169

3.  Cardiac remodeling and arrhythmogenesis are ameliorated by administration of Cx43 mimetic peptide Gap27 in heart failure rats.

Authors:  Claudia M Lucero; David C Andrade; Camilo Toledo; Hugo S Díaz; Katherin V Pereyra; Esteban Diaz-Jara; Karla G Schwarz; Noah J Marcus; Mauricio A Retamal; Rodrigo A Quintanilla; Rodrigo Del Rio
Journal:  Sci Rep       Date:  2020-04-23       Impact factor: 4.379

Review 4.  Mechanisms of Connexin Regulating Peptides.

Authors:  D Ryan King; Meghan W Sedovy; Xinyan Leng; Jianxiang Xue; Samy Lamouille; Michael Koval; Brant E Isakson; Scott R Johnstone
Journal:  Int J Mol Sci       Date:  2021-09-22       Impact factor: 5.923

Review 5.  The Role of Connexin Hemichannels in Inflammatory Diseases.

Authors:  Bo Peng; Chengping Xu; Shuaiwei Wang; Yijie Zhang; Wei Li
Journal:  Biology (Basel)       Date:  2022-02-02

Review 6.  Peptidic Connexin43 Therapeutics in Cardiac Reparative Medicine.

Authors:  Spencer R Marsh; Zachary J Williams; Kevin J Pridham; Robert G Gourdie
Journal:  J Cardiovasc Dev Dis       Date:  2021-05-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.